Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins

Article Properties
  • Language
    English
  • Publication Date
    2024/01/01
  • Indian UGC (journal)
  • Refrences
    75
  • Takuya Kobayakawa Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU)
  • Masaru Yokoyama Pathogen Genomics Center, National Institute of Infectious Diseases
  • Kohei Tsuji Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU)
  • Sayaka Boku Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU)
  • Masaki Kurakami Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU)
  • Masayuki Fujino AIDS Research Center, National Institute of Infectious Diseases
  • Takahiro Ishii Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU)
  • Yutaro Miura Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU)
  • Soshi Nishimura Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU)
  • Kouki Shinohara Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU)
  • Kenichi Yamamoto Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU)
  • Peter Bolah Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU)
  • Osamu Kotani Pathogen Genomics Center, National Institute of Infectious Diseases
  • Tsutomu Murakami AIDS Research Center, National Institute of Infectious Diseases
  • Hironori Sato Pathogen Genomics Center, National Institute of Infectious Diseases
  • Hirokazu Tamamura Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU)
Cite
Kobayakawa, Takuya, et al. “Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins”. Chemical and Pharmaceutical Bulletin, vol. 72, no. 1, 2024, pp. 41-47, https://doi.org/10.1248/cpb.c23-00618.
Kobayakawa, T., Yokoyama, M., Tsuji, K., Boku, S., Kurakami, M., Fujino, M., Ishii, T., Miura, Y., Nishimura, S., Shinohara, K., Yamamoto, K., Bolah, P., Kotani, O., Murakami, T., Sato, H., & Tamamura, H. (2024). Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins. Chemical and Pharmaceutical Bulletin, 72(1), 41-47. https://doi.org/10.1248/cpb.c23-00618
Kobayakawa, Takuya, Masaru Yokoyama, Kohei Tsuji, Sayaka Boku, Masaki Kurakami, Masayuki Fujino, Takahiro Ishii, et al. “Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins”. Chemical and Pharmaceutical Bulletin 72, no. 1 (2024): 41-47. https://doi.org/10.1248/cpb.c23-00618.
Kobayakawa T, Yokoyama M, Tsuji K, Boku S, Kurakami M, Fujino M, et al. Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins. Chemical and Pharmaceutical Bulletin. 2024;72(1):41-7.
Refrences
Title Journal Journal Categories Citations Publication Date
A Small Molecule CXCR4 Inhibitor that Blocks T Cell Line–tropic HIV-1 Infection

The Journal of Experimental Medicine
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
  • Medicine: Medicine (General)
267 1997
Discovery and Development of Anti-HIV Therapeutic Agents: Progress Towards Improved HIV Medication

Current Topics in Medicinal Chemistry
  • Medicine: Therapeutics. Pharmacology
  • Science: Chemistry
60 2019
Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque Assay

Science
  • Science: Science (General)
591 1985
10.1039/D3MD00258F
10.1201/9781315735368